These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 26888181)

  • 1. Circulating fibroblast growth factor-23 plasma levels predict adverse cardiovascular outcomes in patients with diabetes mellitus with coronary artery disease.
    Tuñón J; Fernández-Fernández B; Carda R; Pello AM; Cristóbal C; Tarín N; Aceña Á; González-Casaus ML; Huelmos A; Alonso J; Lorenzo Ó; González-Parra E; Hernández-González I; Mahíllo-Fernández I; López-Bescós L; Egido J
    Diabetes Metab Res Rev; 2016 Oct; 32(7):685-693. PubMed ID: 26888181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sun exposure influences the prognostic power of components of mineral metabolism in patients with coronary artery disease.
    Aceña A; Franco-Peláez JA; Gutierrez-Landaluce C; Pello AM; Cristóbal C; Tarín N; Huelmos A; Carda R; Martín-Mariscal ML; Alonso J; González-Parra E; González-Casaus ML; Lorenzo Ó; López Bescos L; Egido J; Tuñón J
    Nutr Metab Cardiovasc Dis; 2017 Sep; 27(9):762-767. PubMed ID: 28803689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coexistence of low vitamin D and high fibroblast growth factor-23 plasma levels predicts an adverse outcome in patients with coronary artery disease.
    Tuñón J; Cristóbal C; Tarín N; Aceña Á; González-Casaus ML; Huelmos A; Alonso J; Lorenzo Ó; González-Parra E; Mahíllo-Fernández I; Pello AM; Carda R; Farré J; Rodríguez-Artalejo F; López-Bescós L; Egido J
    PLoS One; 2014; 9(4):e95402. PubMed ID: 24748388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential profile in inflammatory and mineral metabolism biomarkers in patients with ischemic heart disease without classical coronary risk factors.
    Pello AM; Cristóbal C; Tarín N; Huelmos A; Aceña Á; Carda R; González-Casaus ML; Alonso J; Lorenzo Ó; Blanco-Colio L; Martín-Ventura JL; Franco Peláez JA; Mahíllo-Fernández I; Farré J; López-Bescós L; Egido J; Tuñón J
    J Cardiol; 2015 Jul; 66(1):22-7. PubMed ID: 25533425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum level of fibroblast growth factor 21 predicts long-term prognosis in patients with both diabetes mellitus and coronary artery calcification.
    Gan F; Huang J; Dai T; Li M; Liu J
    Ann Palliat Med; 2020 Mar; 9(2):368-374. PubMed ID: 32268770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Important abnormalities of bone mineral metabolism are present in patients with coronary artery disease with a mild decrease of the estimated glomerular filtration rate.
    González-Parra E; Aceña Á; Lorenzo Ó; Tarín N; González-Casaus ML; Cristóbal C; Huelmos A; Mahíllo-Fernández I; Pello AM; Carda R; Hernández-González I; Alonso J; Rodríguez-Artalejo F; López-Bescós L; Ortiz A; Egido J; Tuñón J
    J Bone Miner Metab; 2016 Sep; 34(5):587-98. PubMed ID: 26298279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibroblast growth factor 23 (FGF23) and mortality: the Ludwigshafen Risk and Cardiovascular Health Study.
    Brandenburg VM; Kleber ME; Vervloet MG; Tomaschitz A; Pilz S; Stojakovic T; Delgado G; Grammer TB; Marx N; März W; Scharnagl H
    Atherosclerosis; 2014 Nov; 237(1):53-9. PubMed ID: 25200615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma Levels of Monocyte Chemoattractant Protein-1, n-Terminal Fragment of Brain Natriuretic Peptide and Calcidiol Are Independently Associated with the Complexity of Coronary Artery Disease.
    Martín-Reyes R; Franco-Peláez JA; Lorenzo Ó; González-Casaus ML; Pello AM; Aceña Á; Carda R; Martín-Ventura JL; Blanco-Colio L; Martín-Mariscal ML; Martínez-Milla J; Villa-Bellosta R; Piñero A; Navarro F; Egido J; Tuñón J
    PLoS One; 2016; 11(5):e0152816. PubMed ID: 27171378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intact fibroblast growth factor 23 levels predict incident cardiovascular event before but not after the start of dialysis.
    Nakano C; Hamano T; Fujii N; Obi Y; Matsui I; Tomida K; Mikami S; Inoue K; Shimomura A; Nagasawa Y; Okada N; Tsubakihara Y; Rakugi H; Isaka Y
    Bone; 2012 Jun; 50(6):1266-74. PubMed ID: 22425694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parathormone levels add prognostic ability to N-terminal pro-brain natriuretic peptide in stable coronary patients.
    Gutiérrez-Landaluce C; Aceña Á; Pello A; Martínez-Milla J; González-Lorenzo Ó; Tarín N; Cristóbal C; Blanco-Colio LM; Martín-Ventura JL; Huelmos A; López-Castillo M; Alonso J; López Bescós L; Alonso-Pulpón L; González-Parra E; Egido J; Mahíllo-Fernández I; Lorenzo Ó; González-Casaus ML; Tuñón J
    ESC Heart Fail; 2021 Aug; 8(4):2713-2722. PubMed ID: 33932116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-Biomarkers-Clinical Risk Factors for Prediction of Cardiovascular Events in Patients With Coronary Artery Disease.
    Wong YK; Cheung CYY; Tang CS; Au KW; Hai JSH; Lee CH; Lau KK; Cheung BMY; Sham PC; Xu A; Lam KSL; Tse HF
    Arterioscler Thromb Vasc Biol; 2018 Oct; 38(10):2519-2527. PubMed ID: 30354221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of fibroblast growth factor 23 and fetuin--A to coronary atherosclerosis.
    Akin F; Celik O; Altun I; Ayca B; Diker VO; Satılmıs S; Sahin C
    J Diabetes Complications; 2015; 29(4):550-5. PubMed ID: 25772252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between Serum Fibroblast Growth Factor 21 and Coronary Artery Disease in Patients with Type 2 Diabetes.
    Kim WJ; Kim SS; Lee HC; Song SH; Bae MJ; Yi YS; Jeon YK; Kim BH; Kim YK; Kim IJ
    J Korean Med Sci; 2015 May; 30(5):586-90. PubMed ID: 25931789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of diabetes mellitus on vitamin D metabolism in predialysis patients.
    Tanaka H; Hamano T; Fujii N; Tomida K; Matsui I; Mikami S; Nagasawa Y; Ito T; Moriyama T; Horio M; Imai E; Isaka Y; Rakugi H
    Bone; 2009 Nov; 45(5):949-55. PubMed ID: 19631779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth differentiation factor-15 and fibroblast growth factor-23 are associated with mortality in type 2 diabetes - An observational follow-up study.
    Frimodt-Møller M; von Scholten BJ; Reinhard H; Jacobsen PK; Hansen TW; Persson FI; Parving HH; Rossing P
    PLoS One; 2018; 13(4):e0196634. PubMed ID: 29698460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The phosphatonin fibroblast growth factor 23 links calcium-phosphate metabolism with left-ventricular dysfunction and atrial fibrillation.
    Seiler S; Cremers B; Rebling NM; Hornof F; Jeken J; Kersting S; Steimle C; Ege P; Fehrenz M; Rogacev KS; Scheller B; Böhm M; Fliser D; Heine GH
    Eur Heart J; 2011 Nov; 32(21):2688-96. PubMed ID: 21733911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inorganic phosphate and FGF-23 predict outcome in stable systolic heart failure.
    Plischke M; Neuhold S; Adlbrecht C; Bielesz B; Shayganfar S; Bieglmayer C; Szekeres T; Hörl WH; Strunk G; Vavken P; Pacher R; Hülsmann M
    Eur J Clin Invest; 2012 Jun; 42(6):649-56. PubMed ID: 22150123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibroblast growth factor 23 independently predicts adverse outcomes after an acute coronary syndrome.
    Kallmeyer A; Pello A; Cánovas E; Aceña Á; González-Casaus ML; Tarín N; Cristóbal C; Gutiérrez-Landaluce C; Huelmos A; Rodríguez-Valer A; González-Lorenzo Ó; Alonso J; López-Bescós L; Egido J; Mahillo I; Lorenzo Ó; Tuñón J
    ESC Heart Fail; 2024 Feb; 11(1):240-250. PubMed ID: 37950429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes modifies effect of high-phosphate diet on fibroblast growth factor-23 in chronic kidney disease.
    Muras K; Masajtis-Zagajewska A; Nowicki M
    J Clin Endocrinol Metab; 2013 Dec; 98(12):E1901-8. PubMed ID: 24092829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of ESRD and all cause mortality in type 2 diabetes according to circulating levels of FGF-23 and TNFR1.
    Lee JE; Gohda T; Walker WH; Skupien J; Smiles AM; Holak RR; Jeong J; McDonnell KP; Krolewski AS; Niewczas MA
    PLoS One; 2013; 8(3):e58007. PubMed ID: 23526964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.